Mary Sabatini, MD, specializes in reproductive endocrinology and fertility preservation for cancer patients. She is the medical director of the Clinic for Reproductive Health and Cancer.
- Clinical Interests
- Minimally invasive surgery
- Fertility preservation for cancer patients
- Infectious diseases
- Infertility - female
- Infertility - male
- Medical Education
- MD, Columbia University College of Physicians and Surgeons
- PhD, Harvard University
- Residency, Brigham and Women's Hospital
- Board Certifications
- Obstetrics & Gynecology
- Reproductive Endo. & Infertility
- Boston: Massachusetts General Hospital
- Danvers: The Mass General/North Shore Center for Outpatient Care
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
Mary Sabatini, MD, PhD, is the Medical Director of the Oncofertility Clinic and the Medical Director of the Third-Party Reproduction Program in the Reproductive Endocrinology and Infertility Division of the Department of Obstetrics and Gynecology at Massachusetts General Hospital. She is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School.
Her primary research interests include exploring novel approaches to fertility preservation in those diagnosed with cancer and understanding clinical outcomes for women with hereditary cancer syndromes.
Kano M, Sosulski AE, Zhang L, Saatcioglu HD, Wang D, Nagykery N, Sabatini ME, Gao G, Donahoe PK, Pépin D. AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy. Proceedings of the National Academy of Sciences USA. 2017 Feb 28;114(9):E1688-E1697.
Mínguez-Alarcón L, Chiu YH, Messerlian C, Williams PL, Sabatini ME, Toth TL, Ford JB, Calafat AM, Hauser R; EARTH Study Team. Urinary paraben concentrations and in vitro fertilization outcomes among women from a fertility clinic. Fertility & Sterility. 2016 Mar;105(3):714-21.
Hariton E, Bortoletto P, Cardozo ER, Hochberg EP, Sabatini ME. The Role of Oncofertility Clinics in Facilitating Access to Reproductive Specialists.
Accepted and awaiting publication in Journal of Patient Experience
Cardozo E, Karmon A, Longacre MM and Sabatini ME. The Role of Demographics and Diagnosis on Fertility Preservation Decision Making Among Female Cancer Patients of Reproductive Age. Accepted and awaiting publication in Journal of Reproductive Medicine
Hariton E, Kim K, Mumford SL, Palmor M, Bortoletto P, Cardozo ER, Karmon A, Sabatini ME, Styer AK. Total number of Oocytes and Zygotes are Predictive of Live Birth Pregnancy in Fresh Donor Oocyte IVF Cycles
Accepted for publication 2017 – Fertility & Sterility
"Fertility and Cancer: Fertility Preservation and Fertility Sparing Surgery" (Chapter 15) in Translational Advances in Gynecologic Cancers (1st Edition, 2017)
Editors: Michael Birrer & Lorenzo Ceppi
See more publications on PubMed.
New oncofertility research at Mass General offers a promising new paradigm for a reversible contraceptive that may help protect the ovaries during chemotherapy.
55 Fruit Street
Yawkey Center for Outpatient Care
Boston, MA 02114-2696
104 Endicott Street
Danvers, MA 01923-3623